Monroe Capital LLC ("Monroe") announced it acted as joint lead arranger on the funding of a senior credit facility to support ...

Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...

Olympus Partners was recognized for the second consecutive year as a Top 20 performer globally by the 2024 HEC Paris-DowJones Large Buyout Performance Ranking Report. The report names the world's top ...

In a joint, equally-split transaction, the pair of investors have snapped up the Minneapolis-based company from Olympus ...

STAMFORD, Conn., Feb. 13, 2025 /PRNewswire/ -- Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose ...

Monroe Capital announced it acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of Accelevation Holding Company by Olympus Partners. Founded in 2018 and ...

STAMFORD, Conn., Feb. 11, 2025 /PRNewswire/ -- Olympus Partners was recognized for the second consecutive year as a Top 20 performer globally by the 2024 HEC Paris-DowJones Large Buyout ...